Back to Agenda
Seeing Through the Fog of a Pandemic: Building Evidence in Record-Time Through Interventional and Non-Interventional Studies
Session Chair(s)
Virginia Acha, PhD, MSc
AVP, Global Regulatory Policy
Merck Sharpe & Dohme LLC , United States
We will review the practical and governance challenges for the use of registries and observational studies during a pandemic. Panelists will discuss with the audience to explore paths for progress to deliver benefits for patients and public health.
Learning Objective : • Exchange views on the practical guidance and support for establishing, maintaining and closing registries in order to sustain data quality, integrity and access during a pandemic. • Share experience on the drivers for and needs of registry owners for urgent real-time data development and long-term data infrastructure • Understand the views of patients and general public in the use of registries.
Speaker(s)
Title to be Announced
Alison Cave, PhD
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Chief Safety Officer
Panelist
Peter Mol, PharmD, PhD
MEB, Netherlands
CHMP member, NL
Panelist
Carl Glittenberg
Roche, Switzerland
Global Medical Team Lead: Personalised Healthcare in Opthamology
Have an account?